Effect of high-dose nicotine patch on the characteristics of lapse episodes
- PMID: 20658822
- DOI: 10.1037/a0019367
Effect of high-dose nicotine patch on the characteristics of lapse episodes
Abstract
Objective: Nicotine patch improves treatment outcomes, but lapses are still common. To understand the process of relapse on patch, we investigated differences in the antecedents (withdrawal, setting, triggers) of lapse episodes experienced on high-dose (35 mg) nicotine patches versus placebo.
Design: Participants were smokers who lapsed during a randomized, double-blind trial of active patches (n = 100) versus placebo (n = 85). Participants used electronic diaries to monitor their smoking, affect, and activities in real time for 5 weeks during their cessation attempt.
Results: We analyzed 490 lapse episodes (active: 266; placebo: 224). Lapses on nicotine patch were characterized by significantly lower positive affect and higher negative affect than placebo lapses. Participants treated with high-dose patch were also significantly more likely to lapse in situations involving little or no craving. Situational antecedents of lapses on patch resembled those on placebo.
Conclusion: The results suggest that treatment with patch may set a higher threshold for affective stimuli to provoke lapses, but does not change the proximal cues that trigger lapses. This suggests that behavioral relapse-prevention strategies developed for unmedicated smokers should also apply to those treated with nicotine patch.
PsycINFO Database Record (c) 2010 APA, all rights reserved
Similar articles
-
Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.Clin Ther. 2009 Sep;31(9):1957-65. doi: 10.1016/j.clinthera.2009.08.029. Clin Ther. 2009. PMID: 19843485
-
Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.Clin Ther. 2008 Aug;30(8):1461-75. doi: 10.1016/j.clinthera.2008.07.019. Clin Ther. 2008. PMID: 18803988 Clinical Trial.
-
Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence.Addiction. 2012 Jul;107(7):1349-53. doi: 10.1111/j.1360-0443.2012.03801.x. Epub 2012 Mar 22. Addiction. 2012. PMID: 22276996 Clinical Trial.
-
The emerging phenomenon of electronic cigarettes.Expert Rev Respir Med. 2012 Feb;6(1):63-74. doi: 10.1586/ers.11.92. Expert Rev Respir Med. 2012. PMID: 22283580 Review.
-
The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.J Psychopharmacol. 2014 Nov;28(11):1071-9. doi: 10.1177/0269881114548295. Epub 2014 Sep 24. J Psychopharmacol. 2014. PMID: 25253274 Review.
Cited by
-
Factors associated with smoking cessation.Rev Saude Publica. 2015;49:10. doi: 10.1590/s0034-8910.2015049004946. Epub 2015 Feb 27. Rev Saude Publica. 2015. PMID: 25741649 Free PMC article.
-
Examination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation.BMC Public Health. 2015 Dec 21;15:1268. doi: 10.1186/s12889-015-2596-2. BMC Public Health. 2015. PMID: 26689281 Free PMC article. Clinical Trial.
-
Point process analyses of variations in smoking rate by setting, mood, gender, and dependence.Psychol Addict Behav. 2011 Sep;25(3):501-10. doi: 10.1037/a0022178. Psychol Addict Behav. 2011. PMID: 21480683 Free PMC article.
-
Nondaily smokers' experience of craving on days they do not smoke.J Abnorm Psychol. 2015 Aug;124(3):648-59. doi: 10.1037/abn0000063. J Abnorm Psychol. 2015. PMID: 26052617 Free PMC article.
-
Nicotine replacement therapy versus control for smoking cessation.Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5. Cochrane Database Syst Rev. 2018. PMID: 29852054 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical